Stocks › STLN

Starling Oncology, Inc.

STLN·Nasdaq·United States United States·USD
$6.71
-0.20 (-2.89%)
Close · Oct 23, 2026 · Close Prices from Tiingo.com
STLN
Starling Oncology, Inc. · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
STLNS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

Congressional Trades

Recent trades of STLN by members of U.S. Congress · 12 on record · 12 in the last 12 months
All congressional trades →
PoliticianStockTypeFiledTraded
Richard BlumenthalRichard BlumenthalSenate · D · CT STLNStarling Oncology, Inc. · Stock Sale
$15,001 - $50,000
Oct 26, 2026 Sep 18, 2026 Filing ↗
Richard BlumenthalRichard BlumenthalSenate · D · CT STLNStarling Oncology, Inc. · Stock Sale
$1,001 - $15,000
Oct 26, 2026 Sep 23, 2026 Filing ↗
Richard BlumenthalRichard BlumenthalSenate · D · CT STLNStarling Oncology, Inc. · Stock Sale
$15,001 - $50,000
Oct 26, 2026 Sep 22, 2026 Filing ↗
Richard BlumenthalRichard BlumenthalSenate · D · CT STLNStarling Oncology, Inc. · Stock Sale
$15,001 - $50,000
Oct 26, 2026 Sep 18, 2026 Filing ↗
Richard BlumenthalRichard BlumenthalSenate · D · CT STLNStarling Oncology, Inc. · Stock Sale
$1,001 - $15,000
Oct 26, 2026 Sep 22, 2026 Filing ↗
Richard BlumenthalRichard BlumenthalSenate · D · CT STLNStarling Oncology, Inc. · Stock Sale
$1,001 - $15,000
Oct 26, 2026 Sep 18, 2026 Filing ↗
Richard BlumenthalRichard BlumenthalSenate · D · CT STLNStarling Oncology, Inc. · Stock Sale
$1,001 - $15,000
Oct 26, 2026 Sep 23, 2026 Filing ↗
Richard BlumenthalRichard BlumenthalSenate · D · CT STLNStarling Oncology, Inc. · Stock Sale
$15,001 - $50,000
Oct 26, 2026 Sep 22, 2026 Filing ↗
Richard BlumenthalRichard BlumenthalSenate · D · CT STLNStarling Oncology, Inc. · Stock Sale
$15,001 - $50,000
Oct 26, 2026 Sep 18, 2026 Filing ↗
Richard BlumenthalRichard BlumenthalSenate · D · CT STLNStarling Oncology, Inc. · Stock Sale
$1,001 - $15,000
Oct 26, 2026 Sep 22, 2026 Filing ↗
Richard BlumenthalRichard BlumenthalSenate · D · CT STLNStarling Oncology, Inc. · Stock Sale
$1,001 - $15,000
Oct 26, 2026 Sep 18, 2026 Filing ↗
Richard BlumenthalRichard BlumenthalSenate · D · CT STLNStarling Oncology, Inc. · Stock Sale
$15,001 - $50,000
Oct 26, 2026 Sep 22, 2026 Filing ↗

Whale Activity

Institutional 13F positions

No 13F positions in STLN among the institutional filers we track.

KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.

Insider Trading

Net shares bought (+) or sold (−) on the open market by STLN insiders, by quarter · Form 4
-500.0K-250.0K0250.0K500.0K2025 Q1: 02025 Q12025 Q2: 02025 Q22025 Q3: 02025 Q32025 Q4: 02025 Q42026 Q1: 02026 Q12026 Q2: 02026 Q22026 Q3: -286.9K2026 Q32026 Q4: 02026 Q4

Recent Insider Transactions

2 transactions on record · newest first
All insider activity →
InsiderTypeSharesPriceValueDate
Hively BradDirector Sale −298.9K $6.51 $1.9M Aug 21, 2026 Form 4 ↗
Chernett Jorey10% owner Purchase +12.0K $6.54 $78K Aug 14, 2026 Form 4 ↗

Fund Holders

Mutual funds and ETFs holding STLN · SEC Form N-PORT

Funds report their holdings by CUSIP, and STLN could not be matched to one, so no fund holdings are shown.

Activist & Passive Stakes

Schedule 13D / 13G beneficial-ownership filings

No 13D/13G beneficial-ownership filings on record.

Corporate Lobbying

Estimated quarterly lobbying spending reported under the LDA, filings naming Starling Oncology, Inc. as client

No lobbying filings found naming Starling Oncology, Inc. as the client.

Government Contracts

Federal awards to Starling Oncology, Inc. · USAspending

No federal contract awards found for Starling Oncology, Inc..

U.S. Patents

Recent USPTO applications naming Starling Oncology, Inc.

No USPTO patent applications found for Starling Oncology, Inc..

Annual Financials

From STLN's 10-K filings · XBRL

No annual XBRL figures on record for STLN. KeyVex's fundamentals cover about 130 large companies so far.

Stock Splits

Every split and reverse split in the price history

No stock splits in STLN's price history.

Material Events (8-K)

Corporate events filed with the SEC
  • 8-K · Items 5.02Officer / director changeSep 2, 2026
    EDGAR ↗
  • 8-K · Items 1.01, 2.03, 9.01Material agreement · Direct financial obligationAug 21, 2026
    EDGAR ↗

About Starling Oncology, Inc.

From SEC EDGAR company records
Industry (SIC 8011)Services-Offices & Clinics of Doctors of Medicine
SectorHealthcare
HeadquartersCERRITOS, CA
IncorporatedDE
Former namesOncology Institute, Inc., DFP HEALTHCARE ACQUISITIONS CORP.